GLP-1 has also been shown to protect beta cells from apoptosis and stimulate beta-cell proliferation [10, 11]
What are the 4 Main GLP-1 Drugs
Lixisenatide and twice-daily exenatide were compared in the GetGoal-X trial, which found that lixisenatide was not inferior to exenatide in lowering HbA1c ( 0.79% vs
Pfizer CEO Albert Bourla decried the duopoly in his own presentation on Monday
Loos, a professor at the University of Copenhagen and affiliated with a research center supported by the Novo Nordisk Foundation (the maker of Wegovy and Ozempic), noted, "The current model explains only 25% of the variability, and further research is needed to uncover the remaining 75%." However, she also expressed optimism, stating, "By combining genetic and clinical information, the era of personalized medicine, where we can select the best drug for each patient, may be upon us."